Israel Englander Zai Lab LTD Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Zai Lab LTD stock. As of the latest transaction made, Millennium Management LLC holds 138,410 shares of ZLAB stock, worth $3.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,410

Previous 53,368 159.35%

Holding current value

$3.63 Million

Previous $924,000 261.58%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.25 - $24.14 $1.38 Million - $2.05 Million	85,042 Added 159.35%	138,410 $3.34 Million
Q2 2024 Aug 14, 2024	SELL	$13.72 - $21.55 $4.78 Million - $7.51 Million	-348,291 Reduced 86.71%	53,368 $924,000
Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $2.41 Million - $4.05 Million	151,195 Added 60.37%	401,659 $6.43 Million
Q4 2023 Feb 14, 2024	BUY	$22.97 - $30.58 $5.75 Million - $7.66 Million	250,464 New	250,464 $6.85 Million
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $2.68 Million - $5.75 Million	-115,744 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $1.05 Million - $2.43 Million	-37,668 Reduced 24.55%	115,744 $5.09 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $2.69 Million - $5.15 Million	48,941 Added 46.85%	153,412 $9.64 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $3.17 Million - $5.38 Million	30,149 Added 40.57%	104,471 $11 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $4.99 Million - $7.19 Million	39,923 Added 116.06%	74,322 $13.2 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $1.57 Million - $2.39 Million	12,470 Added 56.87%	34,399 $4.59 Million
Q4 2020 Feb 16, 2021	SELL	$81.94 - $135.34 $4.76 Million - $7.86 Million	-58,053 Reduced 72.58%	21,929 $2.97 Million
Q3 2020 Nov 16, 2020	SELL	$73.3 - $89.48 $287,042 - $350,403	-3,916 Reduced 4.67%	79,982 $6.65 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $15.3 Million - $25.8 Million	-312,967 Reduced 78.86%	83,898 $6.89 Million
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $14.3 Million - $23 Million	365,312 Added 1157.77%	396,865 $20.4 Million
Q4 2019 Feb 14, 2020	SELL	$29.79 - $43.06 $5.71 Million - $8.25 Million	-191,559 Reduced 85.86%	31,553 $1.31 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $6.55 Million - $8.1 Million	215,037 Added 2663.0%	223,112 $7.22 Million
Q2 2019 Aug 15, 2019	BUY	$25.73 - $35.79 $207,769 - $289,004	8,075 New	8,075 $282,000
Q1 2019 May 14, 2019	SELL	$21.71 - $31.54 $5.75 Million - $8.35 Million	-264,724 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $155,808 - $257,631	-10,422 Reduced 3.79%	264,724 $6.15 Million
Q3 2018 Nov 14, 2018	SELL	$17.8 - $25.35 $1.94 Million - $2.76 Million	-108,739 Reduced 28.33%	275,146 $5.36 Million
Q2 2018 Aug 14, 2018	BUY	$18.0 - $25.01 $4.96 Million - $6.9 Million	275,794 Added 255.15%	383,885 $8.93 Million
Q1 2018 May 15, 2018	BUY	$20.05 - $26.96 $1.17 Million - $1.58 Million	58,536 Added 118.12%	108,091 $2.31 Million
Q4 2017 Feb 14, 2018	SELL	$21.23 - $34.09 $398,189 - $639,392	-18,756 Reduced 27.46%	49,555 $1.05 Million
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $1.84 Million - $2.13 Million	68,311	68,311 $1.84 Million

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account